13F filer · CIK 2013341
Foresite Capital Management VI LLC
WEST HOLLYWOOD, CA · filing since Q4 2024 · last filing Aug 14, 2026
Reported value
$642.6M
+$182.3M vs prior
Positions
23
New / sold out
8 / 2
Added / reduced
6 / 1
Turnover
10.9%
buys $176.7M · sells $60.2M
Top-10 weight
81.5%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | Seaport Therapeutics, Inc. | +1,779,521 | – | +$38.7M |
| New | Parabilis Medicines, Inc. | +999,044 | – | +$27.3M |
| Added | Celldex Therapeutics, Inc. | +563,800 | +178.5% | +$21.0M |
| Added | GH Research PLC | +625,001 | +198.1% | +$16.8M |
| Added | Jade Biosciences, Inc. | +566,667 | +177.1% | +$12.6M |
| New | Beam Therapeutics Inc. | +330,000 | – | +$11.3M |
| Added | CG Oncology, Inc. | +148,100 | +6.7% | +$10.5M |
| New | ArriVent BioPharma, Inc. | +301,341 | – | +$10.5M |
| Added | AGIOS PHARMACEUTICALS, INC. | +260,000 | +49.5% | +$9.6M |
| New | Aura Biosciences, Inc. | +1,333,334 | – | +$9.5M |
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | Centessa Pharmaceuticals plc | -1,364,019 | -100.0% | $-54.2M |
| Sold out | OnKure Therapeutics, Inc. | -1,445,783 | -100.0% | $-6.0M |
| Reduced | Minerva Neurosciences, Inc. | -1,016 | -0.1% | $-5.6K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | CG Oncology, Inc.COM | 2,369,574 | $168.4M | 26.20% |
| 2 | ALUMIS INC.COM | 4,247,670 | $119.5M | 18.60% |
| 3 | Seaport Therapeutics, Inc.COM | 1,779,521 | $38.7M | 6.02% |
| 4 | Denali Therapeutics Inc.COM | 1,396,771 | $35.9M | 5.59% |
| 5 | Celldex Therapeutics, Inc.COM | 879,713 | $32.7M | 5.09% |
| 6 | AGIOS PHARMACEUTICALS, INC.COM | 785,000 | $29.1M | 4.53% |
| 7 | Corvus Pharmaceuticals, Inc.COM | 1,831,233 | $27.4M | 4.26% |
| 8 | Parabilis Medicines, Inc.COM | 999,044 | $27.3M | 4.26% |
| 9 | GH Research PLCORD | 940,493 | $25.3M | 3.93% |
| 10 | Jade Biosciences, Inc.COM | 886,667 | $19.7M | 3.07% |
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.